Large genomic studies have shown that up to one-third of all cases of HRD in metastatic PC are associated with gross biallelic deletions of the BRCA2 gene, which are not detectable by conventional targeted NGS [14,51,52]. This evidence concerns the gene BRCA2 and pachyonychia congenita.